North America Drug Delivery Systems Market

The North America human drug delivery systems market is expected to reach US$ 1,074,679.7 Mn in 2027 from US$ 572,453.0 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.

Key factors that are driving the growth of the market are rising need for medication among the populace, extensive research and developments projects undertaken by various market players to sustain their leadership in the market leading to launch of new and innovative products as well as a well-established pharmaceutical and medical device industry in the region.

Over the past few decades, Research and development (R&D) in drug delivery devices is increasing across the globe due to the increasing prevalence of the chronic disease. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Various routes of administration are being studied in order to treat these chronic diseases. According to the Centers for Disease Control and Prevention (CDC) in 2019, almost 6 in 10 people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases. Also, cancer is one of the leading cause of death in the North America region. Furthermore, the American Cancer Society (ACS) estimated that in 2018, approximately 1,735,350 new cancer cases were diagnosed. Targeted drug delivery system (TDDS) is a system, which delivers the drug in a controlled manner at a preselected biosite. Diabetes is a life-threatening chronic disease with no specialized cure. Diabetes of all types can lead to various complications in many parts of the body and can increase the overall risk of premature death. For instance, according to the International Diabetes Federation (IDF), in 2017, a number of people with diabetes in North America was approximately 46 million, which is expected to reach 62 million in 2045. Thus, the increasing number of patients suffering from one or more chronic diseases is expected to boost the growth of drug delivery devices market over the coming years.

The US drug delivery systems market is expected to grow at the highest rate during the forecast period. The growth of this market is primarily driven by increasing prevalence of chronic diseases like diabetes, asthma, and others, a growing number of product launches by key players; and increasing use of drug delivery systems for disease management. The market for drug delivery systems in the US region is expected to reach US$ 741,528.96 Mn in 2027 from US$ 388,359.24 Mn in 2018. The growth rate of the market in the region is estimated to be 7.6% during the forecast period.

North America Drug Delivery Systems Market Revenue and Forecasts to 2027 ( US$ Mn)

Get more information on this report Request Free Sample PDF

North America Drug Delivery Systems Strategic Insights

Strategic insights for the North America Drug Delivery Systems provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Drug Delivery Systems Report Scope

North America Drug Delivery Systems Regional Insights

The geographic scope of the North America Drug Delivery Systems refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

NORTH AMERICA DRUG DELIVERY SYSTEMS– MARKET SEGMENTATION

By Route of Administration

• Oral
  • Solid Oral Drugs
  • Liquid Oral Drugs
  • Semi-solid Oral Drugs
• Transmucosal
  • Pulmonary Drug Delivery
    • In-metered Dose Inhalers
    • Dry Powder Inhalers
    • Nebulizers
  • Nasal Drug Delivery
    • Nasal Sprays
    • Nasal Drops
    • Nasal Gels
  • Buccal Drug Delivery
  • Sublingual Drug Delivery
  • Rectal Transmucosal Drug delivery
  • Vaginal Transmucosal Drug Delivery
• Injectable
  • Conventional Injection Devices
  • Self-Injection Devices
    • Needle Free Injectors
    • Pen Injectors
    • Wearable Injectors
• Topical
  • Semi-solid Topical Drug Delivery Formulations
  • Liquid Topical Drug Delivery Formulations
  • Solid Topical Drug Delivery Formulations
  • Transdermal Patches
  • Transdermal Gels
  • Others
• Implantable
  • Active Implantable
  • Passive Implantable
• Ocular
  • Eye Drops & Sprays
  • Gels & Ointments
  • Ocular Inserts
• Drug Coated Contact Lenses

NORTH AMERICA DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION

By Application

• Hospital & Clinics
• Home Care Settings
• Others

NORTH AMERICA DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION

By

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies 

By Country

• U.S
• Canada
• Mexico

Companies Mentioned

• BD
• Novo Nordisk A/S
• 3M
• Boston Scientific Corporation
• Bausch Health Companies Inc.
• Baxter International, Inc.
• Boehringer Ingelheim
• Novartis AG
• GlaxoSmithKline plc.
• Johnson & Johnson Services, Inc.